Skin & hair

Why Men's and Women's Hair-Loss Treatment Differ

Save

The biology behind pattern hair loss is shared across sexes, but the standard treatment path splits early: what's backed by strong, sustained evidence in men isn't automatically the right first move for a woman, and vice versa. Add in the possibility that hair loss isn't pattern-related at all — alopecia areata is a different disease entirely — and treatment choice depends first on an accurate diagnosis, then on what the evidence actually supports for that person's biology.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

The Same Biology, a Different Pattern

Androgenetic hair loss — commonly called pattern hair loss — follows the same basic mechanism in men and women: hair follicles that are sensitive to androgens gradually shrink, producing thinner, shorter hairs with each growth cycle until some stop producing visible hair at all. Androgenetic alopecia is hair loss driven by androgen-sensitive hair follicles progressively miniaturizing over time. Where it shows up differs by sex. Men typically lose hair first at the temples and crown, often progressing toward a fully receded hairline or bald crown over years. Women more often thin diffusely along the part line, with density dropping gradually across the top of the scalp while the frontal hairline usually stays in place. Both patterns typically progress gradually over years rather than appearing suddenly, which is one more reason a fast, patchy change is more likely to be something other than androgenetic hair loss. That difference in pattern is part of why treatment doesn't transfer directly from one sex to the other — the evidence base for each major treatment was built, and tested, on different populations.

What's Proven for Men

For men with androgenetic hair loss, two treatments carry the deepest evidence: topical minoxidil and oral finasteride, both shown across trials to slow loss and, in many people, regrow some hair. A five-year study of men taking finasteride found it markedly decreased the likelihood of developing further visible hair loss compared with placebo, with the benefit holding up over the full follow-up period 1. A broader systematic review and meta-analysis found minoxidil, finasteride, and low-level laser therapy all promote hair growth in men with androgenetic alopecia 2. Of the three, minoxidil and finasteride have the longest track record and the most consistent results; low-level laser devices show a smaller, more variable effect. A fuller side-by-side comparison — hair-loss treatments, ranked by the evidence — breaks down how these options compare on study size and quality, not just whether they work at all.

What's Proven for Women

Topical minoxidil is the most consistently supported option for women with androgenetic hair loss — the same major evidence review covering men's treatments also found it effective in women, making it the closest thing to a universal first-line option 2. Finasteride's evidence base, by contrast, comes almost entirely from studies in men, so it isn't part of the standard toolkit typically offered to women. One alternative some prescribers reach for is spironolactone for women's hair thinning, an off-label hormonal approach with its own evidence base and considerations, covered separately in more depth. Because pattern hair loss in women can look similar to other causes of thinning at a glance, getting the diagnosis right before committing to a treatment matters as much as the treatment choice itself.

When It Isn't Pattern Hair Loss: Alopecia Areata

Not all hair loss is androgenetic. Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles directly, typically causing patchy — rather than diffuse or pattern-based — hair loss, and its course is unpredictable: it can resolve on its own, persist, or spread 3. Telling alopecia areata vs pattern loss apart usually comes down to shape and speed: pattern hair loss thins a predictable zone gradually over months to years, while alopecia areata often appears as one or more distinct round or oval patches, sometimes within weeks, and can affect eyebrows, eyelashes, or a beard as well as the scalp. Alopecia areata is not related to androgens or sex hormones, so it can affect men and women, and any age, without following either pattern-hair-loss template. Because it's an autoimmune condition rather than a hormonal one, minoxidil and finasteride are not the primary tools used for it.

PRP, Lasers, and Newer Systemic Options

Platelet-rich plasma (PRP) injections are one of the more established adjunct options: a systematic review and meta-analysis found PRP improves hair density and thickness in androgenetic hair loss, though the underlying trials vary considerably in protocol and quality, which makes results less predictable than with minoxidil or finasteride 4. It's generally positioned as something added to a regimen rather than a stand-alone replacement for it. For severe alopecia areata that hasn't responded to first-line treatment, oral baricitinib — a JAK1/2 inhibitor taken as a pill — became the first systemic treatment approved specifically for the disease, after two phase 3 trials found it produced significantly more hair regrowth than placebo in adults with severe disease 5. That's a meaningfully different category of treatment: a systemic immune-modulating drug rather than a topical or hormonal one, reserved for more extensive or treatment-resistant disease.

Building a Realistic Plan

Because pattern hair loss and alopecia areata are different diseases with different treatments, and because men's and women's evidence bases for pattern hair loss don't fully overlap, the right starting point depends on an accurate diagnosis first and sex-appropriate options second. Two follow-up questions come up constantly once someone starts: starting hair-loss treatment early versus waiting, and stopping hair-loss treatment once it's working. Both deserve their own answer rather than a single paragraph here, because the right timing and the consequences of stopping depend on specifics — how long the loss has been happening, how advanced it already is, and which treatment is in question. For most people, pattern hair loss is a common, non-dangerous condition — the goal of treatment is slowing or partially reversing it, not treating an emergency.

Common questions

Both are forms of androgenetic hair loss driven by androgen-sensitive follicles gradually shrinking, but the pattern on the scalp differs — men typically lose hair at the hairline and crown, while women usually thin diffusely at the part line with the frontal hairline staying intact. The underlying process is closely related, but the standard treatments for each sex aren't identical.

The strongest, longest-running evidence for oral finasteride comes from studies in men; the major treatment reviews describing its long-term benefit are built on male-pattern data. Minoxidil, by contrast, has evidence supporting its use in both men and women, which is part of why it's the more universal starting point.

Yes, especially early on. Pattern hair loss is gradual and androgen-driven, thinning a predictable area over months to years, while alopecia areata is autoimmune, can appear suddenly, and often shows up as one or more distinct round patches rather than diffuse thinning. A clinician can usually tell them apart on exam.

Reviews of platelet-rich plasma for androgenetic hair loss show it can improve hair density and thickness, but the trials behind it vary a lot in protocol and quality, so results aren't as consistent or predictable as with the better-established treatments. It's generally positioned as an add-on rather than a replacement.

Alopecia areata is an autoimmune condition that can affect anyone, regardless of sex or age — it isn't related to the androgen-driven process behind male or female pattern hair loss. Its course is unpredictable, and while treatments can help hair regrow, there's currently no cure.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When Hair Loss Needs a Closer Look

  • —Sudden patchy or clumpy hair loss, especially in round patches
  • —Hair loss accompanied by scalp pain, burning, redness, or scarring
  • —Hair loss with other new symptoms like unexplained fatigue, weight change, or irregular periods
  • —Rapidly progressing hair loss over weeks rather than months to years

This article is general health information, not medical advice. It cannot diagnose the cause of any individual's hair loss. A clinician who can examine the scalp and hair pattern directly is the right source for that diagnosis and for choosing between treatment options.

References

  1. 1.Kaufman KD, Rotonda J, Shah AK, Meehan AG (2008). Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia. European Journal of Dermatology. PMID 18573712 ✓Five-year data showing oral finasteride markedly decreases the likelihood of developing further visible hair loss versus placebo in men with androgenetic alopecia.
  2. 2.Adil A, Godwin M (2017). The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. PMID 28396101 ✓Minoxidil, finasteride, and low-level laser therapy promote hair growth in men with androgenetic alopecia, and minoxidil is effective in women with androgenetic alopecia.
  3. 3.National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024). Alopecia Areata. NIH / NIAMS. link ✓Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles, typically causing patchy hair loss, with an unpredictable course; treatments can promote regrowth but there is no cure.
  4. 4.Gupta AK, Bamimore MA, Foley KA (2020). Efficacy of non-surgical treatments for androgenetic alopecia: platelet-rich plasma systematic review and meta-analysis. Journal of Dermatological Treatment. PMID 32410524 ✓Platelet-rich plasma injections improve hair density and thickness in androgenetic alopecia, with heterogeneity and variable protocol quality across the underlying studies.
  5. 5.King B, Ohyama M, Kwon O, et al. (2022). Two Phase 3 Trials of Baricitinib for Alopecia Areata. New England Journal of Medicine. doi:10.1056/NEJMoa2110343Two phase 3 trials showing oral baricitinib is superior to placebo for hair regrowth in adults with severe alopecia areata, forming the basis for the first systemic FDA approval in alopecia areata.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library